Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin effect on renal oxygenation in T2DM and healthy controls
NCT04027530Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), diabetic kidney disease (DKD), sponsored by Amsterdam University Medical Center. Started Dec 2020; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT04027530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04027530.